| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/19/2015 | US20150051289 Liquid formulations of hypoglycaemic sulfonamides |
| 02/19/2015 | US20150051287 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases |
| 02/19/2015 | US20150051281 Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases |
| 02/19/2015 | US20150051269 Drug Delivery Conjugate Capable of Controlled Release, and Use Thereof |
| 02/19/2015 | US20150051265 Dually Derivatized Chitosan Nanoparticles and Methods of Making and Using the Same |
| 02/19/2015 | US20150051235 Compositions and Methods for Treating Cardiovascular Diseases |
| 02/19/2015 | US20150051216 Oral spray formulations and methods for administration of sildenafil |
| 02/19/2015 | US20150051200 Gum resin as a carrier for topical application of pharmacologically active agents |
| 02/19/2015 | US20150051198 Highly Concentrated Stable Meloxicam Solutions for Needleless Injection |
| 02/19/2015 | US20150051182 Methods and related compositions for reduction of fat and skin tightening |
| 02/19/2015 | US20150051181 Process for producing nanoparticles laden with active ingredient |
| 02/19/2015 | US20150051172 Pharmaceutical compositions comprising boronic acid compounds |
| 02/19/2015 | US20150051168 Stable liquid pharmaceutical composition containing piroxicam or its pharmaceutically acceptable salt and hyaluronic acid or its pharmaceutically acceptable salt and the manufacturing method thereof |
| 02/19/2015 | US20150051157 Romidepsin formulations and uses thereof |
| 02/19/2015 | US20150051154 Alkylating agents |
| 02/19/2015 | US20150051153 Environmentally Sensitive Compositions |
| 02/19/2015 | US20150051142 Novel method for peroral delivery of insulin and its analogues for therapeutic usage |
| 02/19/2015 | US20150050714 Acryloyloxyethylphosphorylcholine Containing Polymer Conjugates And Their Preparation |
| 02/19/2015 | US20150050416 Coated Solid Dosage Forms |
| 02/19/2015 | US20150050355 Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
| 02/19/2015 | US20150050351 Stereoisomer peptides, their polymer conjugates, their encapsulation into nanoparticles, and uses thereof for the treatment of diseases caused by abnormal angiogenesis. |
| 02/19/2015 | US20150050349 Systems and methods for particle radiation enhanced delivery of therapy |
| 02/19/2015 | US20150050347 Reverse micelle system comprising nucleic acids and use thereof |
| 02/19/2015 | US20150050346 Compositions and methods for treating insulin resistance and diabetes mellitus |
| 02/19/2015 | US20150050340 Sustained-release drug carrier composition |
| 02/19/2015 | US20150050339 Phenylethanoic Acid, Phenylpropanoic Acid and Phenylpropenoic Acid Conjugates and Prodrugs of Hydrocodone, Method of Making and Use Thereof |
| 02/19/2015 | US20150050336 Taste Masking System For Non-Plasticizing Drugs |
| 02/19/2015 | US20150050318 Multivalent nanoemulsion vaccines |
| 02/19/2015 | US20150050307 Materials and methods for producing improved lentiviral vector particles |
| 02/19/2015 | US20150050295 Novel lipids and compositions for intracellular delivery of biologically active compounds |
| 02/19/2015 | US20150050270 Antibodies to bradykinin b1 receptor ligands |
| 02/19/2015 | US20150050262 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 02/19/2015 | US20150050257 Fibrosis causing agent |
| 02/19/2015 | US20150050233 Compositions containing inclusion complexes |
| 02/19/2015 | US20150050219 Coloured solution in particular for use in surgical methods for the treatment of the bodies of humans or animals |
| 02/19/2015 | US20150050212 Cholecystokinin b receptor targeting for imaging and therapy |
| 02/19/2015 | US20150050210 Pharmaceutical formulation comprising bendamustine |
| 02/18/2015 | EP2837392A2 Modified erythropoietin to which water-soluble long-chain molecule is added |
| 02/18/2015 | EP2837391A1 Hypromellose acetate succinate for use as hot-melt extrusion carrier, hot-melt extrusion composition, and method for producing hot-melt extrudate |
| 02/18/2015 | EP2837384A1 Glutathione based delivery system |
| 02/18/2015 | EP2836559A1 Composition comprising an organic diluent and a cellulose ether |
| 02/18/2015 | EP2836533A1 Low band gap conjugated polymeric compositions and applications thereof |
| 02/18/2015 | EP2836238A1 Co-polymer conjugates |
| 02/18/2015 | EP2836237A1 Ultrafine nanoparticles as multimodal contrast agent |
| 02/18/2015 | EP2836236A1 Methods and compositions for preparing a silk microsphere |
| 02/18/2015 | EP2836235A1 Novel sustained release dosage forms |
| 02/18/2015 | EP2836234A1 Vehicles for controlled delivery of different pharmaceutical agents |
| 02/18/2015 | EP2836233A1 Sustained-release formulation |
| 02/18/2015 | EP2836207A1 Composite formulation comprising multi-unit spheroidal tablet (must) encapsulated in hard capsule and method for preparing same |
| 02/18/2015 | EP2836205A1 Esterified cellulose ethers having a specific substituent distribution |
| 02/18/2015 | EP2836203A1 Vesicular formulations for use in the treatment of pain or reduced mobility of a joint |
| 02/18/2015 | EP2836199A1 Fulvestrant formulations |
| 02/18/2015 | EP2836196A1 Preparation for topical application to mucosa containing polyhexanide as active ingredient |
| 02/18/2015 | EP2836195A1 System and method for multiphasic release of growth factors |
| 02/17/2015 | US8957223 Ligand-conjugated monomers |
| 02/17/2015 | US8957202 Enterosoluble and intestinal-enzyme-biodegradable materials and method for preparing the same |
| 02/17/2015 | US8957191 Nucleic acid comprising zwitterionic nucleotides |
| 02/17/2015 | US8957186 Recombinant protein for intracellular delivery of siRNA and composition comprising the same |
| 02/17/2015 | US8957115 Pheromone compositions and methods of use |
| 02/17/2015 | US8957112 Cream gels comprising at least one retinoid and benzoyl peroxide |
| 02/17/2015 | US8957110 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 02/17/2015 | US8957082 Tetrahydropyrrolopyrimidinediones and their use in therapy |
| 02/17/2015 | US8957050 Bone implant materials comprising cross-linked bioactive hydrogel matrices |
| 02/17/2015 | US8957048 Compositions for the treatment of dry eye |
| 02/17/2015 | US8957034 Drugs and gene carrier particles that rapidly move through mucous barriers |
| 02/17/2015 | US8957023 Methods for making proteins containing free cysteine residues |
| 02/17/2015 | US8957022 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 02/17/2015 | US8957017 Dipeptoid prodrugs and their use |
| 02/17/2015 | US8957016 Tumor activated prodrugs |
| 02/17/2015 | US8956863 Agents from cells |
| 02/17/2015 | US8956825 Intranuclear protein transduction through a nucleoside salvage pathway |
| 02/17/2015 | US8956667 Methods of identifying potential components for targeted drug delivery compositions |
| 02/17/2015 | US8956659 Fulvestrant nanosphere/microsphere and preparative method and use thereof |
| 02/17/2015 | US8956658 Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
| 02/17/2015 | US8956657 Stable formulations for lyophilizing therapeutic particles |
| 02/17/2015 | US8956651 Oral formulations and lipophilic salts of methylnal trexone |
| 02/17/2015 | US8956649 Orally effective methylphenidate extended release powder and aqueous suspension product |
| 02/17/2015 | US8956646 Zwitterionic lipids |
| 02/17/2015 | US8956645 Water-soluble pharmaceutical composition comprising at least one therapeutically active substance having hydrophobic properties and at least one compound selected from among sialoglycosphingolipids, glycosphingolipids or a mixture of sialoglycosphingolipids and glycosphingolipids |
| 02/17/2015 | US8956638 Biocompatible poly (amic acid) and method of preparation thereof |
| 02/17/2015 | US8956616 Constructs binding to phosphatidylserine and their use in disease treatment |
| 02/17/2015 | US8956604 Conjugates comprising an N-oxime bond and associated methods |
| 02/17/2015 | US8956603 Amphiphilic compounds and self-assembling compositions made therefrom |
| 02/17/2015 | US8956598 Hydrocarbon mixtures and use thereof |
| 02/17/2015 | US8956572 Single use system for sterilely producing lipid-nucleic acid particles |
| 02/17/2015 | CA2748365C Pharmaceutical composition of lyophilized formulation and preparation method of the same |
| 02/17/2015 | CA2673976C Gel composition for treating mycosis |
| 02/17/2015 | CA2592532C Sesamin/episesamin compositions with improved bioavailability |
| 02/17/2015 | CA2578784C Compositions containing alpha-2-adrenergic agonist components |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2511814C Polymer conjugates of interferon-beta with enhanced biological potency |
| 02/12/2015 | WO2015021254A1 Polymeric biomaterials derived from monomers comprising hydroxyacids and phenol compounds and their medical uses |
| 02/12/2015 | WO2015021044A1 Compositions and methods for stimuli-responsive release of a therapeutic agent |
| 02/12/2015 | WO2015020286A1 Stable triple-layer capsule using poorly water-soluble substance, manufacturing method therefor and cosmetic composition using same |
| 02/12/2015 | WO2015020240A1 Entecavir microspheres and pharmaceutical composition for parenteral administration containing same |
| 02/12/2015 | WO2015020191A1 Calcium agent |
| 02/12/2015 | WO2015020186A1 Tablet composition |
| 02/12/2015 | WO2015020153A1 Beraprost-containing patch |
| 02/12/2015 | WO2015020139A1 Nanoparticles and nanoparticle composition, and method for producing nanoparticles and nonparticle composition |
| 02/12/2015 | WO2015020068A1 Ester polymer phosphate derivative and dispersant |